VacZine Analytics  



Our products - ExpertREACT
ExpertREACT is a free* service to our subscribers.

The aim of ExpectREACT is to respond to events within the vaccines sector and communicate to our clients their potential impact and significance. It will also provide summary discussion pieces
from our ongoing work with global opinion leaders.
*conditions apply


Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up with e-mail address to ExpertREACT
Current market dynamics:

November 2007
December 2007
January 2008
February 2008
March 2008

April 2008
New Staph vaccines: risk-based or population based approach?
Cancer vaccines - progress with Oncophage does not change long, difficult road to success.
Increasing patent activity and company investment in vaccine R&D signals long-term confidence in sector.

May 2008
Anti-smoking vaccines: expect a long, hard fight between NABI and Cytos.
Intercell AG: a multitude of technology platforms. Product-related revenue now needed.
Novartis Vaccines: all guns blazing on meningitis.

June 2008
Novartis Vaccines: diverse early stage pipeline will force rivals to act.

July 2008
Respiratory syncytial virus - not just for kids..
Group A Streptococcus vaccines - considering the issues.
Sanofi to acquire Acambis - the logical next step.

August 2008
New US flu vaccine recommendations: continued focus on children.

September 2008
Norovirus vaccines: time for re-examination?.

October 2008
The vaccine R&D pipeline - is influenza being overdone?
GSK Bio and AFFiRiS - are therapeutic vaccines back in fashion?
48th Annual ICAAC/IDSA, Washington, DC - vaccines update.

November 2008
Clostridium difficile - the bad news and possibly good news.

© 2008 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains